ROHN WILLIAM R

CIK 00011932074 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001193207

Recent Transactions

50 trades

Award
CERUS CORP$CERS
Option (Right to Buy)
2006-01-03+15,000→ 15,000 total
Award
PHARMACYCLICS INC
Option (Right to Buy Stock)
2006-01-03+4,764→ 4,764 total
Award
CERUS CORP$CERS
Option (Right to Buy)
2006-01-03+15,000→ 15,000 total
Award
PHARMACYCLICS INC
Option (Right to Buy Stock)
2006-01-03+4,764→ 4,764 total
Award
PHARMACYCLICS INC
Option (Right to Buy Stock)
2005-10-03+1,892→ 1,892 total
Award
PHARMACYCLICS INC
Option (Right to Buy Stock)
2005-10-03+1,892→ 1,892 total
Award
CERUS CORP$CERS
Option (Right to Buy)
2005-09-01+3,333→ 3,333 total
Award
CERUS CORP$CERS
Option (Right to Buy)
2005-09-01+3,333→ 3,333 total
Award
PHARMACYCLICS INC
Option (Right to Buy Stock)
2005-07-01+2,321→ 2,321 total
Award
PHARMACYCLICS INC
Option (Right to Buy Stock)
2005-07-01+2,321→ 2,321 total
Award
PHARMACYCLICS INC
Option (Right to Buy Stock)
2005-01-03+1,425→ 1,425 total
Award
PHARMACYCLICS INC
Option (Right to Buy Stock)
2005-01-03+1,425→ 1,425 total
Award
CERUS CORP$CERS
Option (Right to Buy)
2005-01-01+3,334→ 3,334 total
Award
CERUS CORP$CERS
Option (Right to Buy)
2005-01-01+3,334→ 3,334 total
Award
METABASIS THERAPEUTICS INC
Stock Option (Right to Buy)
2004-12-01+20,000→ 20,000 total
Award
METABASIS THERAPEUTICS INC
Stock Option (Right to Buy)
2004-12-01+20,000→ 20,000 total
Award
PHARMACYCLICS INC
Option (Right to Buy Stock)
2004-10-01+1,910→ 1,910 total
Award
CERUS CORP$CERS
Option (Right to Buy)
2004-09-01+3,333→ 3,333 total
Award
CERUS CORP$CERS
Option (Right to Buy)
2004-09-01+3,333→ 3,333 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.67/sh−1,600→ 144,221 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.52/sh−200→ 145,821 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.51/sh−2,494→ 146,021 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.72/sh−431→ 140,462 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.70/sh−1,248→ 141,293 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.50/sh−16,947→ 148,515 total
Exercise/Conversion
BIOGEN INC.$BIIB
Common Stock
2004-08-31$6.92/sh+25,000→ 165,462 total
Exercise/Conversion
BIOGEN INC.$BIIB
Stock Option (right-to-buy)
2004-08-31−25,000→ 140,462 total
Exercise/Conversion
BIOGEN INC.$BIIB
Common Stock
2004-08-31$6.92/sh+25,000→ 165,462 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.68/sh−780→ 143,441 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.72/sh−431→ 140,462 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.68/sh−780→ 143,441 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.69/sh−900→ 142,541 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.52/sh−200→ 145,821 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.50/sh−16,947→ 148,515 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.51/sh−2,494→ 146,021 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.67/sh−1,600→ 144,221 total
Exercise/Conversion
BIOGEN INC.$BIIB
Stock Option (right-to-buy)
2004-08-31−25,000→ 140,462 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.71/sh−400→ 140,893 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.70/sh−1,248→ 141,293 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.71/sh−400→ 140,893 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-31$58.69/sh−900→ 142,541 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-30$58.60/sh−8,600→ 175,962 total
Exercise/Conversion
BIOGEN INC.$BIIB
Stock Option (right-to-buy)
2004-08-30−8,275→ 0 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-30$58.55/sh−1,475→ 0 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-30$58.57/sh−3,900→ 186,762 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-30$58.52/sh−900→ 7,375 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-30$58.55/sh−600→ 0 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-30$58.70/sh−3,100→ 166,362 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-30$58.53/sh−2,100→ 5,275 total
Sale
BIOGEN INC.$BIIB
Common Stock
2004-08-30$58.67/sh−1,800→ 169,462 total

Companies

Recent Filings

Address

IDEC PHARMACEUTICALS CORPORATION 3030 CALLAN ROAD

SAN DIEGO, CA, 92121

View on SEC.gov